Here’s Why Rivian (RIVN) Stock Is Rising

Rivian Automotive Inc (NASDAQ: RIVN) shares are trading higher by 10.46% to $15.31 Wednesday morning after the company reported better-than-expected first-quarter results.

Rivian Automotive Inc (NASDAQ:RIVN) shares are trading higher by 10.46% to $15.31 Wednesday morning after the company reported better-than-expected first-quarter results.

What Happened?

Rivian Automotive reported quarterly losses of $1.25 per share which beat the analyst consensus estimate of a loss of $1.58.

The company also reported quarterly sales of $661.00 million which beat the analyst consensus estimate of $642.22 million by 2.9%. This sales figure represents a marked 596% increase over sales of $95.00 million in the same period last year.

Rivian reported production of 9,395 units in the first quarter and 7,946 deliveries. The company has produced over 35,000 vehicles since it began production as of the end of the first quarter.

“During the first quarter of 2023, R1 production continued to grow quarter-over-quarter and EDV is ramping production after the successful introduction of our in-house motor and lithium iron phosphate battery pack,” the company said…Read More

According to data from Benzinga Pro, RIVN has a 52-week high of $40.86 and a 52-week low of $11.68.

Total
0
Shares
Related Posts
Read More

Immuron Said Deprioritizing SARS-CoV-2 Research to Focus on Clinical Development of More Advanced Stage Therapeutic Drug Candidates

Immuron Limited (ASX: IMC; NASDAQ: IMRN), a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform for prevention and treatment of gut-mediated diseases; today announced that it has deprioritized SARS-CoV-2 research to focus on the clinical development of our more advanced stage therapeutic drug candidates.

IMRN

Read More

Precision Optics Enters Into Production And Technology Licensing Agreement For Single-Use Ophthalmic Program; Under The Agreement, POC Has Received A One-Time Upfront Payment Of $600,000 For These Technology Rights

Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced it has signed a production and technology

POCI